Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review
Evgeny A. Ermakov, Irina A. Mednova, Anastasiia S. Boiko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2215-2215
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Association of Peripheral Inflammatory Biomarkers and Growth Factors Levels with Sex, Therapy and Other Clinical Factors in Schizophrenia and Patient Stratification Based on These Data
Evgeny A. Ermakov, Mark M. Melamud, Anastasiia S. Boiko, et al.
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 836-836
Open Access | Times Cited: 17
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment
Giuseppe De Simone, Benedetta Mazza, Licia Vellucci, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 975-975
Open Access | Times Cited: 16
From Skin and Gut to the Brain: The Infectious Journey of the Human Commensal Fungus Malassezia and Its Neurological Consequences
Bharati Naik, Jayaprakash Sasikumar, Shankar Das
Molecular Neurobiology (2024)
Closed Access | Times Cited: 5
Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder
Ekaterina V. Mikhalitskaya, N. Vyalova, Evgeny A. Ermakov, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1460-1460
Open Access | Times Cited: 11
Comprehensive bioinformatics analysis identifies hub genes associated with immune cell infiltration in early-onset schizophrenia
Shasha Wu, Tailian Xue, Yilin Li, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Limited evidence of association between dysregulated immune marker levels and telomere length in severe mental disorders
Monica Bettina Elkjær Greenwood Ormerod, Thor Ueland, Monica Aas, et al.
Acta Neuropsychiatrica (2025) Vol. 37
Closed Access
Predicting antipsychotic responsiveness using a machine learning classifier trained on plasma levels of inflammatory markers in schizophrenia
Jie Yin Yee, S. J. Phua, Yuen Mei See, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Scientific status analysis of exercise benefits for vascular cognitive impairment: Evidence of neuroinflammation
Wei Zhang, Jing He, Yuxin Wang, et al.
Journal of Neuroimmunology (2025) Vol. 402, pp. 578574-578574
Closed Access
Unraveling the potential of neuroinflammation and autophagy in schizophrenia
Hongxia Tao, Cheng‐Xiang Wang, Chuan Zou, et al.
European Journal of Pharmacology (2025) Vol. 997, pp. 177469-177469
Closed Access
Neuroinflammation Profiling of Brain Cytokines Following Repeated Blast Exposure
Lanier Heyburn, Andrew Batuure, Donna M. Wilder, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12564-12564
Open Access | Times Cited: 9
Association between elevated serum matrix metalloproteinase-2 and tumor necrosis factor-α, and clinical symptoms in male patients with treatment-resistant and chronic medicated schizophrenia
Haidong Yang, Ruijie Peng, Man Yang, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Dysregulation of interleukin-8 is involved in the onset and relapse of schizophrenia: An independent validation and meta-analysis
Junwei Yan, Qingrong Xia, Xuejun Sun, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 133, pp. 111018-111018
Closed Access | Times Cited: 3
Spotlight on pro-inflammatory chemokines: regulators of cellular communication in cognitive impairment
Chenxu Wang, Jia‐Yi Wang, Zhichao Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
The causal relationship between immune cell traits and schizophrenia: a Mendelian randomization analysis
Jianbin Du, Ancha Baranova, Guofu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Potential Inflammatory Biomarkers for Major Depressive Disorder Related to Suicidal Behaviors: A Systematic Review
Ka Young Kim, Ki Young Shin, Keun‐A Chang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13907-13907
Open Access | Times Cited: 7
CX3C chemokine: Hallmarks of fibrosis and ageing
Xuanning Chen, Yiling Yang, Siyuan Sun, et al.
Pharmacological Research (2024) Vol. 208, pp. 107348-107348
Open Access | Times Cited: 2
Psychoneuroimmunology of Mood Disorders
Antônio Lúcio Teixeira, Juliete Nathali Scholl, Moisés Evandro Bauer
Methods in molecular biology (2024), pp. 49-72
Closed Access | Times Cited: 2
Building Predictive Models for Schizophrenia Diagnosis with Peripheral Inflammatory Biomarkers
E.A. Kozyrev, Evgeny A. Ermakov, Anastasiia S. Boiko, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1990-1990
Open Access | Times Cited: 5
Interplay of G-proteins and Serotonin in the Neuroimmunoinflammatory Model of Chronic Stress and Depression: A Narrative Review
Evgeni Gusev, Alexey Sarapultsev
Current Pharmaceutical Design (2023) Vol. 30, Iss. 3, pp. 180-214
Closed Access | Times Cited: 5
Different Directions of Effects of Polyclonal IgG Antibodies from Patients with Schizophrenia and Healthy Individuals on Cell Death In Vitro: A Pilot Study
E. Epimakhova, L. Smirnova, Daria V. Kazantseva, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3168-3179
Open Access | Times Cited: 4
Linking enlarged choroid plexus with plasma analyte and structural phenotypes in clinical high risk for psychosis: A multisite neuroimaging study
Deepthi Bannai, Martin Reuter, Rachal Hegde, et al.
Brain Behavior and Immunity (2023) Vol. 117, pp. 70-79
Open Access | Times Cited: 4
Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients
Carlos Fernández-Pereira, Maria Aránzazu Penedo, Adrián Alonso-Núñez, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Inhibition of reactive oxygen species production accompanying alternatively activated microglia by risperidone in a mouse ketamine model of schizophrenia
Risako Fujikawa, Jun Yamada, Shoichiro Maeda, et al.
Journal of Neurochemistry (2024)
Closed Access | Times Cited: 1
Genetics of suicide ideation. A role for inflammation and neuroplasticity?
Fabrizio Turiaco, Fiammetta Iannuzzo, Antonio Bruno, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024) Vol. 274, Iss. 7, pp. 1527-1541
Open Access | Times Cited: 1
Circulating inflammatory cytokines influencing schizophrenia: a Mendelian randomization study
Yao-Ting Li, Xuezhen Zeng
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top